LOGIN  |  REGISTER
Cue Biopharma
Cue Biopharma

Brookdale Senior Living Reports March 2024 Occupancy

April 08, 2024 | Last Trade: US$6.61 0.54 8.90

NASHVILLE, Tenn., April 8, 2024 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE: BKD) reported today its consolidated occupancy for March 2024.

March 2024 Occupancy Table

March 2024 Observations

  • March's weighted average occupancy increased 180 basis points year-over-year to 77.9%, remaining flat sequentially to February's weighted average occupancy.
  • March's increase over the prior year March reflected a continued monthly trend of accelerated year-over-year improvement in the first quarter, and represents the Company's twenty-ninth consecutive month of year-over-year weighted average occupancy growth.
  • Demonstrating an improvement from normal pre-pandemic seasonality, first quarter 2024 weighted average occupancy decreased (50) basis points compared to the fourth quarter 2023.

About Brookdale Senior Living

Brookdale Senior Living Inc. is the nation's premier operator of senior living communities. The Company is committed to its mission of enriching the lives of the people it serves with compassion, respect, excellence, and integrity. The Company, through its affiliates, operates independent living, assisted living, memory care, and continuing care retirement communities. Through its comprehensive network, Brookdale helps to provide seniors with care, connection, and services in an environment that feels like home. The Company's expertise in healthcare, hospitality, and real estate provides residents with opportunities to improve wellness, pursue passions, make new friends, and stay connected with loved ones. Brookdale, through its affiliates, operates and manages 652 communities in 41 states as of March 31, 2024, with the ability to serve approximately 59,000 residents. Brookdale's stock trades on the New York Stock Exchange under the ticker symbol BKD. For more information, visit brookdale.com or connect with Brookdale on Facebook or YouTube.

 

Recursion

Stock Quote

Featured Stock

C4 Therapeutics

C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...

CLICK TO LEARN MORE

Featured Stock

Compass Therapeutics

Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB